Enobosarm ((2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide) (also known as ostarine, GTx-024, and MK-2866) is an investigational selective androgen receptor modulator (SARM) from GTX, Inc for treatment of conditions such as muscle wasting and osteoporosis, formerly under development by Merck & Company.

CAS：841205-47-8
中文别名：(S)-N-(4-氰基-3-(三氟甲基)苯基)-3-(4-氰基苯氧基)-2-羟基-2-甲基丙酰胺;
英文别名：ostarine;GTx-024;(2S)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide;MK-2866;
分子式：C19H14F3N3O3
分子量：389.328
精确质量：389.099
Psa：106.14
Logp：3.29026

MDL号：MFCD16877675

密度：1.4±0.1g/cm3
沸点：632.3±55.0°Cat760mmHg
闪点：336.2±31.5°C
蒸汽压：0.0±2.0mmHgat25°C
折射率：1.578
储存条件：-20°C，惰性气体氛围